Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Jan 18;14(1):e238097.
doi: 10.1136/bcr-2020-238097.

Novel SLC12A3 mutation in Gitelman syndrome

Rita Veríssimo  1 , Luís Leite de Sousa  2 , Tiago J Carvalho  2 , Pedro Fidalgo  2
Affiliations
Case Reports

Novel SLC12A3 mutation in Gitelman syndrome

Rita Veríssimo et al. BMJ Case Rep. .

Abstract

Gitelman syndrome (GS) is an autosomal recessive disease characterised by the presence of hypokalaemic metabolic alkalosis with hypomagnesaemia and hypocalciuria. The prevalence of this disease is 1-10/40 000. GS is usually associated with mild and non-specific symptoms and many patients are only diagnosed in adulthood. The disease is caused by mutations in the SLC12A3 gene. We present the case of a 49-year-old man referred to a nephrology appointment due to persistent hypokalaemia and hypomagnesaemia. Complementary evaluation revealed hypokalaemia, hypomagnesaemia, metabolic alkalosis, hyperreninaemia, increased chloride and sodium urinary excretion, and reduced urinary calcium excretion. Renal function, remainder serum and urinary ionogram, and renal ultrasound were normal. A diagnosis of GS was established and confirmed with genetic testing which revealed a novel mutation in SLC12A3 (c.1072del, p.(Ala358Profs*12)). This novel mutation extends the spectrum of known SLC12A3 gene mutations and further supports the allelic heterogeneity of GS.

Keywords: fluid electrolyte and acid-base disturbances; genetics; renal medicine.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. Blanchard A, Bockenhauer D, Bolignano D, et al. . Gitelman syndrome: consensus and guidance from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int 2017;91:24–33. 10.1016/j.kint.2016.09.046 - DOI - PubMed
    1. Wolyniec W, Jakubowska SK-, Nagel M, et al. . A case report of Gitelman syndrome resulting from two novel mutations in SLC12A3 gene. Nefrologia 2016;36:304–9. 10.1016/j.nefro.2015.04.006 - DOI - PubMed
    1. Knoers NVAM, Levtchenko EN. Gitelman syndrome. Orphanet J Rare Dis 2008;3:1–6. 10.1186/1750-1172-3-22 - DOI - PMC - PubMed
    1. Ji W, Foo JN, O'Roak BJ, O’Roak BJ, et al. . Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet 2008;40:592–9. 10.1038/ng.118 - DOI - PMC - PubMed
    1. Shao L, Liu L, Miao Z, et al. . A novel SLC12A3 splicing mutation skipping of two exons and preliminary screening for alternative splice variants in human kidney. Am J Nephrol 2008;28:900–7. 10.1159/000141932 - DOI - PubMed

Publication types

Substances

LinkOut - more resources